Harvard cardiologist a key player in Guidant deal
13373
A Harvard cardiologist hopes to teach healthcare giant Johnson &amp; Johnson some new tricks. Beverly H. Lorell took a leave from her academic job last year to become chief medical and technology officer for Guidant Corp. The post puts her at the center of the record $25.4 billion deal rolled out yesterday in which Guidant agreed to be purchased by ...
560518
New York (dpa) - Health-care conglomerate Johnson &amp; Johnson is in advanced negotiations to buy defibrillator maker Guidant Corp.
251371
Wall Street may be facing its worst financial storm in years, but billionaire buyout king Henry Kravis is forging ahead with the biggest deals in U.S. history. Kravis's firm, Kohlberg Kravis Roberts, has made deals for $123 billion in acquisitions this year, more than its three chief rivals combi...
257829
Guidant Corp.&#39;s stent business is like a model strutting down a runway wearing last year&#39;s fashions, some industry watchers say.
152330
Johnson &amp; Johnson announced a $25.4bn (Â£13.1bn) deal yesterday to buy Guidant Corporation, giving the healthcare company a stake in the fast-growing market for devices that regulate heartbeats.
385483
Henry H. McVey, Morgan Stanleyâs chief United States investment strategist, said that he was joining the hedge fund Fortress Investment Group.
182817
Drug giant Johnson & Johnson agrees to buy Guidant Corp, a key player in the heart technology market, for $25.4bn.
143623
David Mott, a Dartmouth-educated Wall Street investment banker, is increasingly leveraging his reputation in the local and national biotech communities.-The Washington Post
546307
Johnson &amp; Johnson (nyse: JNJ - news - people ) is said to be in advanced talks to buy medical device maker Guidant (nyse: GDT - news - people ) for more than $24 billion.
717588
Indianapolis-based Guidant Corp., which co-promotes Johnson &amp; Johnson&#39;s Cypher drug-coated heart stent, says the device&#39;s market share has risen by as much as half, helped by Boston Scientific Corp.
470326
Johnson &amp; Johnson said late last night it will acquire Guidant for $23.9 billion, a move that will give the big drug maker a bigger share of the explosive market for heart devices.
756854
Berkshire Hathaway Inc., the investment company run by billionaire Warren Buffett, named another billionaire, Microsoft Corp. founder Bill Gates, as a director.
330580
J.P. Morgan Chase & Co. JPM.N plans  to buy a majority stake in the hedge fund Highbridge Capital  Management, the companies said on Monday, a sign that Wall  Street is seeking a bigger role in the rapidly growing  hedge-fund industry.
32462
Johnson &amp; Johnson, the US medical and consumer goods group, is in advanced discussions to buy Guidant, a maker of medical devices, in a deal that could be worth about $24bn (Â£12bn).
368114
Johnson &amp; Johnson announced last night that will buy medical-device maker Guidant for $23.9 billion in cash and stock. The deal, approved by both boards but subject to regulator approval, is one of the largest
22941
Beverly H. Lorell took a leave from her academic job last year to become chief medical and technology officer for Guidant Corp. The post puts her at the center
521877
INDIANAPOLIS - New Jersey-based health care products giant Johnson &amp; Johnson is buying Guidant Corp., one of the world&#39;s top makers of cardiac devices, for about $25.4 billion in cash and stock.